Company Filing History:
Years Active: 2023-2025
Title: The Innovations of Benjamin Boyerinas
Introduction
Benjamin Boyerinas is an accomplished inventor based in Brookline, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapies for various diseases. With a total of two patents to his name, Boyerinas is recognized for his innovative approaches to adoptive T cell therapies.
Latest Patents
Boyerinas's latest patents include the TGFβ signal convertor and the TGFBeta signal convertor. Both patents focus on improved compositions for adoptive T cell therapies aimed at treating, preventing, or ameliorating symptoms associated with cancer, infectious diseases, autoimmune diseases, inflammatory diseases, and immunodeficiencies. These advancements hold promise for enhancing the effectiveness of treatments in the medical field.
Career Highlights
Throughout his career, Boyerinas has worked with notable companies in the biotechnology sector. He has been associated with 2seventy Bio, Inc. and Regeneron Pharmaceuticals, Inc., where he has contributed to groundbreaking research and development efforts. His work has been instrumental in advancing therapeutic options for patients.
Collaborations
[This section has been skipped due to space constraints.]
Conclusion
Benjamin Boyerinas is a notable inventor whose work in biotechnology is paving the way for innovative therapies. His patents reflect a commitment to improving patient outcomes in the treatment of serious diseases. His contributions to the field are significant and continue to inspire advancements in medical science.